Peptide TherapeuticsPeer Reviewed

Lymphocyte-to-procalcitonin ratio: a new predictor of prognosis in COVID-19.

Authors (4)
Furkan Çağrı OğuzlarEmergency Medicine Department, Medical Faculty of Suleyman Demirel University, Isparta, Turkey.
Hamit Hakan ArmağanEmergency Medicine Department, Medical Faculty of Suleyman Demirel University, Isparta, Turkey.
Teslime Eryavuz ŞengülEmergency Medicine Department, Döşemealtı State Hospital, Antalya, Turkey.
Ezgi CesurEmergency Medicine Department, Kütahya City Hospital, Kütahya, Turkey. drezgiyagyemez@gmail.com.
BMC infectious diseases
Unknown
Published
Oct 13, 2025
View Original

Abstract

Abstract not available - data parsing issue resolved

Keywords

COVID-19LymphocytesProcalcitonin

Article Metrics

Sourcepubmed

Related Research

Explore more articles in this research category to discover related studies and findings.

View more in Peptide Therapeutics